Angiotensin II participates in mitochondrial thermogenic functions via the activation of glycolysis in chemically induced human brown adipocytes

Sci Rep. 2024 May 11;14(1):10789. doi: 10.1038/s41598-024-61774-0.

Abstract

Brown adipocytes are potential therapeutic targets for the prevention of obesity-associated metabolic diseases because they consume circulating glucose and fatty acids for heat production. Angiotensin II (Ang II) peptide is involved in the pathogenesis of obesity- and cold-induced hypertension; however, the mechanism underlying the direct effects of Ang II on human brown adipocytes remains unclear. Our transcriptome analysis of chemical compound-induced brown adipocytes (ciBAs) showed that the Ang II type 1 receptor (AGTR1), but not AGTR2 and MAS1 receptors, was expressed. The Ang II/AGTR1 axis downregulated the expression of mitochondrial uncoupling protein 1 (UCP1). The simultaneous treatment with β-adrenergic receptor agonists and Ang II attenuated UCP1 expression, triglyceride lipolysis, and cAMP levels, although cAMP response element-binding protein (CREB) phosphorylation was enhanced by Ang II mainly through the protein kinase C pathway. Despite reduced lipolysis, both coupled and uncoupled mitochondrial respiration was enhanced in Ang II-treated ciBAs. Instead, glycolysis and glucose uptake were robustly activated upon treatment with Ang II without a comprehensive transcriptional change in glucose metabolic genes. Elevated mitochondrial energy status induced by Ang II was likely associated with UCP1 repression. Our findings suggest that the Ang II/AGTR1 axis participates in mitochondrial thermogenic functions via glycolysis.

Keywords: Adaptive thermogenesis; Angiotensin II; Brown adipocytes; Glycolysis; Mitochondria; UCP1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes, Brown* / drug effects
  • Adipocytes, Brown* / metabolism
  • Angiotensin II* / metabolism
  • Angiotensin II* / pharmacology
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Glucose / metabolism
  • Glycolysis* / drug effects
  • Humans
  • Lipolysis / drug effects
  • Mitochondria* / drug effects
  • Mitochondria* / metabolism
  • Receptor, Angiotensin, Type 1 / genetics
  • Receptor, Angiotensin, Type 1 / metabolism
  • Thermogenesis* / drug effects
  • Uncoupling Protein 1* / genetics
  • Uncoupling Protein 1* / metabolism

Substances

  • Angiotensin II
  • Uncoupling Protein 1
  • Receptor, Angiotensin, Type 1
  • Glucose
  • UCP1 protein, human
  • Cyclic AMP Response Element-Binding Protein